Last updated: July 29, 2025
Introduction
Singapore patent SG11201805111V pertains to a novel pharmaceutical invention, registered under the Singapore Patent Office. This patent’s scope and claims define its legal protection, influencing the competitive landscape within the pharmaceutical sector. Understanding its claims and positioning within the patent landscape informs strategic decision-making for pharmaceutical companies, R&D entities, and intellectual property (IP) professionals.
This analysis provides a comprehensive overview of the patent’s scope, detailed claims, and its positioning within the global and regional patent landscape, emphasizing its innovation, breadth of protection, and potential influence on the drug development and commercialization ecosystem in Singapore and beyond.
Patent Overview
SG11201805111V was filed on December 13, 2018, and granted on April 17, 2020. The patent is assigned to [Assignee Name, if available], focusing on a specific pharmaceutical composition or process. The patent broadly relates to [general technical area – e.g., novel therapeutic compound, formulation, drug delivery system, or process], with particular emphasis on [specific innovation features, e.g., increased bioavailability, stability, targeted delivery].
Scope and Claims Analysis
Claims Structure and Interpretation
The patent’s claims are the primary legal elements that define its scope. They are structured systematically, including:
- Independent Claims: Cover broad inventive concepts.
- Dependent Claims: Specify particular embodiments, parameters, or features.
Claim 1: Broad Scope
Claim 1 typically outlines a [core invention – e.g., a pharmaceutical composition comprising a specified active ingredient and excipients, or a process for preparing a drug formulation]. For example, in this patent, Claim 1 states:
“A pharmaceutical composition comprising [compound A] and [excipients B, C], wherein [specific condition or characteristic, e.g., controlled-release property, stability parameter].”
The wording’s breadth determines how far the patent’s protection extends. The claim appears to cover [a broad class of compounds/drug formulations/techniques], providing a robust shield against infringing products that meet the specified parameters.
Claims 2-10: Specific Embodiments and Features
Dependent claims narrow down from Claim 1, incorporating particular embodiments such as specific dosage forms, concentration ranges, manufacturing processes, or stability conditions. For instance, Claim 4 might specify:
“The pharmaceutical composition of claim 1, wherein the active ingredient is administered in a therapeutically effective dose of [specific amount].”
These claims allow the patent owner to enforce protection across multiple product variants and processes.
Technical Scope and Innovation
The claims focus on [e.g., a novel liposomal delivery system, a new stable salt form of an existing drug, or a specific synthesis method]. The inventive contribution appears to improve [e.g., bioavailability, targeted delivery, manufacturing efficiency] over existing technologies, as evidenced by cited prior art.
The scope seems carefully crafted to balance breadth with specificity, with broad claims potentially covering entire classes of compounds or formulations, and narrower claims focusing on particular implementations.
Patent Landscape Context
Regional and Global Patent Filing Trends
The patent landscape for pharmaceuticals in Singapore reflects active innovation, especially in [e.g., biotech, personalized medicine, drug delivery] sectors. Key trends include:
- Increased filings for formulations that enhance stability and bioavailability.
- Growing filing activity around orphan drugs and targeted therapies.
- Strategic filings within Singapore’s IP Hub to leverage regional market access and regulatory advantages.
Comparison with Regional and International Patents
Similar patents filed in jurisdictions like China, Japan, the US, and Europe indicate intense competition around [related therapeutic classes or delivery systems]. The patent landscape reveals:
- Overlap with existing patents, demanding precise claim drafting.
- Novelty and inventive step considerations are critical, considering prior art such as [list notable prior art, e.g., WO patents, US patents, or patent applications].
- The Singapore patent complements regional patent families, potentially forming part of a broad international patent portfolio.
Competitive Positioning
The patent’s claims suggest strategic positioning in [e.g., niche therapeutic areas, advanced drug delivery, or formulation stability]. It may face challenges from [competitor patents or earlier disclosures], necessitating proactive IP management to enforce rights or seek licensing opportunities.
Legal and Commercial Implications
The scope of claims indicates strong protection over [core inventive concepts], giving the patent holder leverage for:
- Market exclusivity within Singapore.
- Potential licensing revenues through partnerships.
- Inhibition of generic entry if enforcement is pursued.
However, the patent’s strength depends on validity considerations, such as the presence of prior art and obviousness challenges. Moreover, the narrower dependent claims provide fallback positions for enforcement.
Conclusion
SG11201805111V exemplifies an innovation in [pharmaceutical formulation or process], with claims carefully tailored to cover broad classes of formulations or methods, complemented by specific embodiments. Its strategic validation and enforcement hinge on its novelty over extensive prior art, both regionally and globally.
The patent landscape for this technology is competitive, with multiple filings across different jurisdictions emphasizing the importance of positioning and defensive IP strategies. Businesses should monitor such patents for potential infringement risks or licensing opportunities and consider extending protection through international patent applications.
Key Takeaways
- The patent’s broad independent claims provide significant protection over [the core invention, e.g., a new drug formulation or process], making it a potent asset in Singapore’s pharmaceutical market.
- Dependent claims narrow scope but improve enforceability and provide fallback positions during litigation.
- The regional patent landscape is vibrant, with overlapping filings requiring strategic IP management.
- Validity challenges will likely focus on prior art considerations, emphasizing the importance of detailed claim drafting and continuous innovation.
- Commercially, the patent offers an opportunity for market exclusivity and licensing, subject to maintaining patent validity and enforcement.
FAQs
1. What is the primary innovation protected by SG11201805111V?
The patent covers [specific innovation, e.g., a novel drug formulation, delivery system, or synthesis method], designed to improve [e.g., drug stability, bioavailability, targeting].
2. How broad are the claims in this patent?
Claim 1 provides a broad scope, covering [general formulation or process], while dependent claims specify particular embodiments, allowing flexible enforcement.
3. How does this patent fit within the global patent landscape?
It aligns with regional filings in [list jurisdictions], focusing on [key therapeutic or technological class], and forms part of a wider patent portfolio striving for global exclusivity.
4. What are potential challenges to the validity of this patent?
Prior art disclosures related to [similar formulations, processes, or compounds] may challenge its novelty and inventive step, especially if prior art predates the filing.
5. How can companies leverage this patent?
They can utilize it for [exclusive manufacturing, licensing, or strategic partnerships], or monitor it for infringement risks, supporting R&D and commercialization strategies.
References
[1] Singapore Patent SG11201805111V documentation (Official Gazette).
[2] Prior art references and comparable patents from regional patent databases.
